172 related articles for article (PubMed ID: 35344062)
1. The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study.
Yang G; Nie P; Yan L; Zhang M; Wang Y; Zhao L; Li M; Xie F; Xie H; Li X; Xiang F; Wang N; Cheng N; Zhao X; Wang N; Wang Y; Chen C; Yun C; Cui J; Duan S; Zhang R; Hao D; Wang X; Wang Z; Niu H
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2949-2959. PubMed ID: 35344062
[TBL] [Abstract][Full Text] [Related]
2. A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study.
Nie P; Yang G; Wang Y; Xu Y; Yan L; Zhang M; Zhao L; Wang N; Zhao X; Li X; Cheng N; Wang Y; Chen C; Wang N; Duan S; Wang X; Wang Z
Eur Radiol; 2023 Dec; 33(12):8858-8868. PubMed ID: 37389608
[TBL] [Abstract][Full Text] [Related]
3. A preoperative CT-based deep learning radiomics model in predicting the stage, size, grade and necrosis score and outcome in localized clear cell renal cell carcinoma: A multicenter study.
Nie P; Liu S; Zhou R; Li X; Zhi K; Wang Y; Dai Z; Zhao L; Wang N; Zhao X; Li X; Cheng N; Wang Y; Chen C; Xu Y; Yang G
Eur J Radiol; 2023 Sep; 166():111018. PubMed ID: 37562222
[TBL] [Abstract][Full Text] [Related]
4. Incremental value of radiomics-based heterogeneity to the existing risk criteria in predicting recurrence of hepatocellular carcinoma after liver transplantation.
Nie P; Zhang J; Miao W; Duan S; Wang T; Zhang J; Gu J; Wang N; Zhang R; Wang X; Yang G; Rao W; Wang Z
Eur Radiol; 2023 Sep; 33(9):6608-6618. PubMed ID: 37012548
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrence after nephrectomy: Comparison of predictive ability of validated risk models.
Palumbo C; Perri D; Zacchero M; Bondonno G; Martino JD; D'Agate D; Volpe A
Urol Oncol; 2022 Apr; 40(4):167.e1-167.e7. PubMed ID: 35034803
[TBL] [Abstract][Full Text] [Related]
6. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
Ficarra V; Novara G; Galfano A; Brunelli M; Cavalleri S; Martignoni G; Artibani W
BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313
[TBL] [Abstract][Full Text] [Related]
7. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer.
Patel N; Hakansson A; Ohtake S; Muraki P; Proudfout JA; Liu Y; Webber L; Ibarra A; Liu VYT; Davicioni E; Chamie K; Pantuck A; Shuch B
Cancer Med; 2023 Mar; 12(5):6437-6444. PubMed ID: 36397716
[TBL] [Abstract][Full Text] [Related]
10. Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma.
Blackmur JP; Gaba F; Fernando D; Williams S; O'Donnell M; McNeill A; Stewart GD; Leung S; Laird A
Urol Oncol; 2021 Jul; 39(7):438.e11-438.e21. PubMed ID: 34023196
[TBL] [Abstract][Full Text] [Related]
11. Development of a CT-assessed adiposity nomogram for predicting outcome in localized ccRCC.
Li X; Zhang S; Huang X; Lin D; Zhou J
Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38842727
[TBL] [Abstract][Full Text] [Related]
12. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
13. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.
Parker WP; Cheville JC; Frank I; Zaid HB; Lohse CM; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2017 Apr; 71(4):665-673. PubMed ID: 27287995
[TBL] [Abstract][Full Text] [Related]
14. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
15. ST6Gal-I predicts postoperative clinical outcome for patients with localized clear-cell renal cell carcinoma.
Liu HO; Wu Q; Liu WS; Liu YD; Fu Q; Zhang WJ; Xu L; Xu JJ
Asian Pac J Cancer Prev; 2014; 15(23):10217-23. PubMed ID: 25556450
[TBL] [Abstract][Full Text] [Related]
16. Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models.
Martella O; Galatioto GP; Necozione S; Pomante R; Vicentini C
Arch Ital Urol Androl; 2011 Sep; 83(3):121-7. PubMed ID: 22184835
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.
Lamb GW; Aitchison M; Ramsey S; Housley SL; McMillan DC
Br J Cancer; 2012 Jan; 106(2):279-83. PubMed ID: 22166802
[TBL] [Abstract][Full Text] [Related]
18. Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma.
Kroeger N; Lebacle C; Hein J; Rao PN; Nejati R; Wei S; Burchardt M; Drakaki A; Strother M; Kutikov A; Uzzo R; Pantuck AJ
Eur J Cancer; 2022 Jun; 168():68-76. PubMed ID: 35461012
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
He H; Jin Z; Dai J; Wang H; Sun J; Xu D
Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
[TBL] [Abstract][Full Text] [Related]
20. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
